Related Experiment Video
Updated: May 10, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
Alcoholic cardiomyopathy and cardiovascular events - an insight from the Liptov region
1Liptov Hospital, Department of Internal Medicine, ICU, Liptovsky, Mikulas, Slovakia. peter.kycina@gmail.com
Insights
Heavy alcohol consumption did not significantly impact cardiovascular events or echocardiographic parameters in consumers over a 4-year period. No significant differences were found in heart function, biochemical markers, or major cardiovascular events between groups.
Area of Science:
- Cardiology
- Alcohol-related research
- Clinical investigation
Background:
- Heavy alcohol consumption is a known risk factor for cardiovascular disease.
- Understanding the specific impact on cardiac structure and function is crucial for public health.
- Previous studies show varied results on the direct effects of heavy drinking on the heart.
Purpose of the Study:
- To investigate the association between heavy alcohol consumption (≥80g/day) and cardiovascular events.
- To evaluate echocardiographic parameters in heavy alcohol consumers.
- To compare cardiovascular outcomes in individuals with different daily alcohol intake levels over 4 years.
Main Methods:
- 100 heavy alcohol consumers (≥80g/day) without pre-existing cardiovascular disease were recruited.
- Participants were divided into two groups based on daily alcohol intake.
- A 4-year follow-up included clinical evaluation, echocardiography, biochemical analysis, and monitoring for cardiovascular events and rhythm disorders.
Main Results:
- No significant differences were observed in ejection fraction (EF) or left atrium diameter (LA) between groups.
- Left ventricular end-diastolic diameter (LVEDD) showed a non-significant trend towards being larger in the higher intake group (p=0.09).
- No significant differences were found in the incidence of diabetes mellitus, heart failure, atrial fibrillation, stroke, delirium, or myocardial infarction between the groups.
Conclusions:
- Heavy alcohol consumption, even at doses ≥80g/day, did not lead to significant differences in echocardiographic parameters or cardiovascular events over 4 years.
- The study suggests that within the studied heavy drinking population, cardiac function and event rates were comparable.
- Further research may be needed to explore potential long-term or subtle effects not captured in this cohort.
Aim:
This study was conducted to study the association between alcohol consumption and cardiovascular events and echocardiographical parameters in 100 consumers with the average daily dose <120 g and ≥120 g of alcohol per day during a 4-year follow-up.
Methods:
100 patients/heavy alcohol consumers (on average ≥ 80 g daily), with no cardiovascular disease, divided into 2 groups, underwent a baseline echocardiographic and clinical evaluation and were followed-up for cardiovascular events, biochemical analysis and rhythm disorder for 4 years.
Results:
Data regarding the dose and duration of alcohol consumption showed a low correlation and nonlinear character between the duration of alcohol consumption and monitored parameters. There were no differences between the groups in the echo-parameters ejection fraction EF (p=0.43), in the diameter of left atrium LA (p=0.51). Left chamber - LVEDD - was slightly bigger in the group with a heavier drinking pattern (p=0.09). There were no differences in biochemical parameters between the groups. When comparing these two groups of consumers the percentage of diabetes mellitus (p=0.283), episodes of heart failure (p=0.308), atrial fibrillation (p=0.652), cerebral vascular accident (p=0.722) and delirium (p=0.559) were not significantly different; only 2 subjects suffered from myocardial infarction during the follow-up.
Conclusion:
We conclude, that no significant differences (p<0.05) between the two groups of heavy alcohol consumers were observed in echo parameters, biochemical values and cardiovascular events (Tab. 4, Ref. 28).
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Cardiomyopathy IV: Restrictive Cardiomyopathy